GLA c.197A>G ;(p.E66G)

Variant ID: X-100658971-T-C

NM_000169.2(GLA):c.197A>G;(p.E66G)

This variant was identified in 8 publications

View GRCh38 version.




Publications:


Fabry Disease in Slovakia: How the Situation Has Changed over 20 Years of Treatment.

Journal Of Personalized Medicine
Jurickova, Katarina K; Jungova, Petra P; Petrovic, Robert R; Mattosova, Slavomira S; Hlavata, Tereza T; Kostalova, Ludmila L; Hlavata, Anna A
Publication Date: 2022-06-01

Variant appearance in text: GLA: E66G
PubMed Link: 35743707
Variant Present in the following documents:
  • Main text
  • jpm-12-00922.pdf
View BVdb publication page



Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry disease.

Clinical Genetics
Germain, Dominique P DP; Levade, Thierry T; Hachulla, Eric E; Knebelmann, Bertrand B; Lacombe, Didier D; Seguin, Vanessa Leguy VL; Nguyen, Karine K; Noël, Esther E; Rabès, Jean-Pierre JP
Publication Date: 2022-04

Variant appearance in text: GLA: Glu66Gly
PubMed Link: 34927718
Variant Present in the following documents:
  • Main text
  • CGE-101-390.pdf
View BVdb publication page



In Vitro and In Vivo Amenability to Migalastat in Fabry Disease.

Molecular Therapy. Methods & Clinical Development
Lenders, Malte M; Stappers, Franciska F; Brand, Eva E
Publication Date: 2020-12-11

Variant appearance in text: GLA: E66G
PubMed Link: 32995357
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



A Comparative Effectiveness Study of Newborn Screening Methods for Four Lysosomal Storage Disorders.

International Journal Of Neonatal Screening
Sanders, Karen A KA; Gavrilov, Dimitar K DK; Oglesbee, Devin D; Raymond, Kimiyo M KM; Tortorelli, Silvia S; Hopwood, John J JJ; Lorey, Fred F; Majumdar, Ramanath R; Kroll, Charles A CA; McDonald, Amber M AM; Lacey, Jean M JM; Turgeon, Coleman T CT; Tucker, Justin N JN; Tang, Hao H; Currier, Robert R; Isaya, Grazia G; Rinaldo, Piero P; Matern, Dietrich D
Publication Date: 2020-06

Variant appearance in text: GLA: 197A>G; E66G
PubMed Link: 32802993
Variant Present in the following documents:
  • Main text
  • IJNS-06-00044.pdf
View BVdb publication page



Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases.

Scientific Reports
Šimčíková, Daniela D; Heneberg, Petr P
Publication Date: 2019-12-09

Variant appearance in text: GLA: E66G
PubMed Link: 31819097
Variant Present in the following documents:
  • 41598_2019_54976_MOESM2_ESM.xlsx, sheet 8
View BVdb publication page



Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients.

Clinical Genetics
Germain, Dominique P DP; Fouilhoux, Alain A; Decramer, Stéphane S; Tardieu, Marine M; Pillet, Pascal P; Fila, Marc M; Rivera, Serge S; Deschênes, Georges G; Lacombe, Didier D
Publication Date: 2019-08

Variant appearance in text: GLA: E66G
PubMed Link: 30941742
Variant Present in the following documents:
  • Main text
  • CGE-96-107.pdf
View BVdb publication page



Comparative study of structural changes caused by different substitutions at the same residue on α-galactosidase A.

Plos One
Saito, Seiji S; Ohno, Kazuki K; Sakuraba, Hitoshi H
Publication Date: 2013

Variant appearance in text: GLA: E66G
PubMed Link: 24386359
Variant Present in the following documents:
  • Main text
  • pone.0084267.pdf
View BVdb publication page



Pharmacological chaperone therapy for Fabry disease.

Proceedings Of The Japan Academy. Series B, Physical And Biological Sciences
Ishii, Satoshi S
Publication Date: 2012

Variant appearance in text: GLA: E66G
PubMed Link: 22241068
Variant Present in the following documents:
  • pjab-88-018.pdf
View BVdb publication page